To study the therapeutic capacity of anti-PD-L1 on intracranial lesions, the tumor was placed in the right frontal lobe, where the tumor uncontrollably grows, resulting in 100% mortality after approximately 3 weeks. Here, CD274 is linked to neoplasm.